1-2 of 2
Jackie Kennedy-Wilde
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Expansion, Persistence and Pharmacodynamic Profile of ADI-001, a First-in-Class Allogeneic CD20-Targeted CAR Gamma Delta T Cell Therapy, in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Monica A Moreno, Jackie Kennedy-Wilde, Andrew D Wrong, Nadine Jahchan, Francesco Galimi, Yining Ye, Rose Lai, Blake T Aftab
Journal: Blood
Blood (2023) 142 (Supplement 1): 3478.
https://doi.org/10.1182/blood-2023-181919
Published: 2023
Journal Articles

A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies

Sattva S. Neelapu, Don A. Stevens, Mehdi Hamadani, Matthew J. Frank, Houston Holmes, Aya Jacobovits, John Hinkle, Jackie Kennedy-Wilde, Ori Maller, Bayarmagnai Weinstein, Francesco Galimi, Rose K. Lai, David B. Miklos
Journal: Blood
Blood (2022) 140 (Supplement 1): 4617–4619.
https://doi.org/10.1182/blood-2022-157400
Published: 2022